By inhibiting the NLRP3 inflammasome, it reduced the expression of fibrosis markers, including collagen-I, collagen-III, collagen-IV, and α-SMA, thereby alleviating myocardial fibrosis and cardiac dysfunction following MI (154). Here, NLRP3 is linked to Myocardial fibrosis.